Effects of lithospermic acid on hIAPP aggregation and amyloid-induced cytotoxicity by multiple analytical methods

Mukherjee, 2015, Type 2 diabetes as a protein misfolding disease, Trends Mol. Med., 21, 439, 10.1016/j.molmed.2015.04.005 Mukherjee, 2017, Prion-like protein aggregates and type 2 diabetes, Cold Spring Harb. Perspect. Med., 7, 10.1101/cshperspect.a024315 Costes, 2018, Targeting protein misfolding to protect pancreatic beta-cells in type 2 diabetes, Curr. Opin. Pharmacol., 43, 104, 10.1016/j.coph.2018.08.016 Per, 2011, Islet amyloid polypeptide, islet amyloid, and diabetes mellitus, Physiol. Rev., 91, 795, 10.1152/physrev.00042.2009 Xin, 2018, Conformation-dependent manipulation of human islet amyloid polypeptide fibrillation by shiitake-derived Lentinan, ACS Appl. Mater. Interfaces, 10, 31069, 10.1021/acsami.8b11078 Asthana, 2018, IAPP in type II diabetes: basic research on structure, molecular interactions, and disease mechanisms suggests potential intervention strategies, Biochim. Biophys. Acta Biomembr., 1765, 10.1016/j.bbamem.2018.02.020 Kiriyama, 2018, Role and cytotoxicity of amylin and protection of pancreatic islet beta-cells from amylin cytotoxicity, Cells, 7, 95, 10.3390/cells7080095 Cooper, 1987, Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients, Proc. Natl. Acad. Sci., 84, 8628, 10.1073/pnas.84.23.8628 Potter, 2010, Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts, Proc. Natl. Acad. Sci., 107, 4305, 10.1073/pnas.0909024107 Engel, 2009, Membrane permeabilization by islet amyloid polypeptide, Chem. Phys. Lipids, 160, 1, 10.1016/j.chemphyslip.2009.03.008 Sciacca, 2018, Amyloid growth and membrane damage: current themes and emerging perspectives from theory and experiments on Abeta and hIAPP, Biochim. Biophys. Acta Biomembr., 1625, 10.1016/j.bbamem.2018.02.022 Rawat, 2018, Membranes as modulators of amyloid protein misfolding and target of toxicity, Biochim. Biophys. Acta Biomembr., 1863, 10.1016/j.bbamem.2018.04.011 Jha, 2009, Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes, J. Mol. Biol., 389, 907, 10.1016/j.jmb.2009.04.077 Smith, 2009, Induction of negative curvature as a mechanism of cell toxicity by Amyloidogenic peptides: the case of islet amyloid polypeptide, J. Am. Chem. Soc., 131, 4470, 10.1021/ja809002a Brender, 2008, Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide, J. Am. Chem. Soc., 130, 6424, 10.1021/ja710484d Brender, 2007, Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes, Biochim. Biophys. Acta, 1768, 2026, 10.1016/j.bbamem.2007.07.001 Camargo, 2017, Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate, Elife, 6 Sciacca, 2012, Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation, Biochemistry, 51, 7676, 10.1021/bi3009888 Brender, 2012, Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective, Acc. Chem. Res., 45, 454, 10.1021/ar200189b Sahoo, 2019, A cationic polymethacrylate-copolymer acts as an agonist for beta-amyloid and an antagonist for amylin fibrillation, Chem. Sci., 10, 3976, 10.1039/C8SC05771K Sequeira, 2017, Unfolding novel mechanisms of polyphenol flavonoids for better glycaemic control: targeting pancreatic islet amyloid polypeptide (IAPP), Nutrients, 9, 10.3390/nu9070788 Beghyn, 2008, Natural compounds: leads or ideas? bioinspired molecules for drug discovery, Chem. Biol. Drug Des., 72, 3, 10.1111/j.1747-0285.2008.00673.x Dhouafli, 2018, Inhibition of protein misfolding and aggregation by natural phenolic compounds, Cell. Mol. Life Sci., 75, 3521, 10.1007/s00018-018-2872-2 Xu, 2018, Natural products for the treatment of type 2 diabetes mellitus: pharmacology and mechanisms, Pharmacol. Res., 130, 451, 10.1016/j.phrs.2018.01.015 Wang, 2008, Pharmacokinetics and metabolism of lithospermic acid by LC/MS/MS in rats, Int. J. Pharm., 350, 240, 10.1016/j.ijpharm.2007.09.001 Yamamoto, 2000, Caffeic acid oligomers in Lithospermum erythrorhizon cell suspension cultures, Phytochemistry, 53, 651, 10.1016/S0031-9422(99)00623-8 Chan, 2015, Anti-oxidative and hepatoprotective effects of lithospermic acid against carbon tetrachloride-induced liver oxidative damage in vitro and in vivo, Oncol. Rep., 34, 673, 10.3892/or.2015.4068 Lin, 2015, Lithospermic acid attenuates 1-methyl-4-phenylpyridine-induced neurotoxicity by blocking neuronal apoptotic and neuroinflammatory pathways, J. Biomed. Sci., 22, 37, 10.1186/s12929-015-0146-y Liu, 2008, Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats, Chem. Biol. Interact., 176, 137, 10.1016/j.cbi.2008.07.003 Rovnyagina, 2018, Binding of thioflavin T by albumins: an underestimated role of protein oligomeric heterogeneity, Int. J. Biol. Macromol., 108, 284, 10.1016/j.ijbiomac.2017.12.002 Mahdavimehr, 2018, Effect of fibrillation conditions on the anti-amyloidogenic properties of polyphenols and their involved mechanisms, Int. J. Biol. Macromol., 118, 552, 10.1016/j.ijbiomac.2018.06.109 de Almeida, 2017, 1,2,3,4,6-penta- O -galloyl-β- d -glucopyranose binds to the N-terminal metal binding region to inhibit amyloid β -protein oligomer and fibril formation, Int. J. Mass Spectrom., 420, 24, 10.1016/j.ijms.2016.09.018 Young, 2015, Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry, Nat. Chem., 7, 73, 10.1038/nchem.2129 Young, 2014, Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors, J. Am. Chem. Soc., 136, 660, 10.1021/ja406831n Khemtemourian, 2011, Low pH acts as inhibitor of membrane damage induced by human islet amyloid polypeptide, J. Am. Chem. Soc., 133, 15598, 10.1021/ja205007j Li, 2016, The effects of chondroitin sulfate and serum albumin on the fibrillation of human islet amyloid polypeptide at phospholipid membranes, Phys. Chem. Chem. Phys., 18, 12000, 10.1039/C5CP07642K Lee, 2019, Zinc boosts EGCG’s hIAPP amyloid inhibition both in solution and membrane, Biochim. Biophys. Acta Proteins Proteomics, 1867, 529, 10.1016/j.bbapap.2018.11.006 Ruotolo, 2008, Ion mobility-mass spectrometry analysis of large protein complexes, Nat. Protoc., 3, 1139, 10.1038/nprot.2008.78 Cabaleiro-Lago, 2008, Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles, J. Am. Chem. Soc., 130, 15437, 10.1021/ja8041806 Krishnan, 2012, Conserved features of intermediates in amyloid assembly determine their benign or toxic states, Proc. Natl. Acad. Sci., 109, 11172, 10.1073/pnas.1209527109 Trott, 2010, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem., 31, 455 Hirashima, 1999, Three-dimensional pharmacophore hypotheses of octopamine receptor responsible for the inhibition of sex-pheromone production in Helicoverpa armigera, J. Mol. Graph. Model., 17, 43, 10.1016/S1093-3263(99)00019-4 Morris, 2009, AutoDock4 and Autodocktools4: automated docking with selective receptor flexibility, J. Comput. Chem., 30, 2785, 10.1002/jcc.21256 Nanga, 2011, Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment, Biochim. Biophys. Acta, 1808, 2337, 10.1016/j.bbamem.2011.06.012 Huang, 2012, NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG, J. Mol. Biol., 416, 108, 10.1016/j.jmb.2011.12.023 Marek, 2012, Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects, Biochemistry, 51, 8478, 10.1021/bi300574r Dupuis, 2009, Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct Amyloidogenic precursor, J. Am. Chem. Soc., 131, 18283, 10.1021/ja903814q Dupuis, 2011, The amyloid formation mechanism in human IAPP: dimers have β-Strand monomer−monomer interfaces, J. Am. Chem. Soc., 133, 7240, 10.1021/ja1081537 Kayed, 1999, Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro, J. Mol. Biol., 287, 781, 10.1006/jmbi.1999.2646 Susa, 2014, Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions, J. Am. Chem. Soc., 136, 12912, 10.1021/ja504031d Konijnenberg, 2016, Opposite structural effects of Epigallocatechin-3-gallate and dopamine binding to alpha-Synuclein, Anal. Chem., 88, 8468, 10.1021/acs.analchem.6b00731 Xue, 2017, Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation, R. Soc. Open Sci., 4, 10.1098/rsos.160696 Hudson, 2009, The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds, FEBS J., 276, 5960, 10.1111/j.1742-4658.2009.07307.x Caillon, 2013, Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation, Biochim. Biophys. Acta, 1828, 2091, 10.1016/j.bbamem.2013.05.014 Knight, 2004, Phospholipid catalysis of diabetic amyloid assembly, J. Mol. Biol., 341, 1175, 10.1016/j.jmb.2004.06.086 Pithadia, 2016, Influence of a curcumin derivative on hIAPP aggregation in the absence and presence of lipid membranes, Chem. Commun., 52, 942, 10.1039/C5CC07792C Pithadia, 2016, Inhibition of IAPP aggregation and toxicity by natural products and derivatives, J. Diabetes Res., 2016, 10.1155/2016/2046327 Li, 2014, Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis, Biomaterials, 35, 8596, 10.1016/j.biomaterials.2014.06.056 Ren, 2018, Tanshinones inhibit hIAPP aggregation, disaggregate preformed hIAPP fibrils, and protect cultured cells, J. Mater. Chem. B, 6, 56, 10.1039/C7TB02538F Ke, 2019, Mitigation of amyloidosis with Nanomaterials, Adv. Mater., 10.1002/adma.201901690 Velander, 2017, Natural product-based amyloid inhibitors, Biochem. Pharmacol., 139, 40, 10.1016/j.bcp.2017.04.004